Search

Search Results
Results 89021 - 89030 of 90437 for cancer
  • Solu-Medrol
    Drug - 12 May 2026
    Consumer Medicine Information (CMI) about Solu-Medrol intended for persons living in Australia.
  • How AI and QSAR Modeling Accelerate Ligand-Based Drug Design
    Life Sciences - 11 May 2026
    Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and accelerating therapeutic development.
  • Tripacel
    Drug - 8 May 2026
    Consumer Medicine Information (CMI) about Tripacel intended for persons living in Australia.
  • Adacel Polio
    Drug - 8 May 2026
    Consumer Medicine Information (CMI) about Adacel Polio intended for persons living in Australia.
  • Evoltra
    Drug - 5 May 2026
    Consumer Medicine Information (CMI) about Evoltra intended for persons living in Australia.
  • Multi-transporter models for blood-brain barrier studies
    Health - 23 Apr 2026
    Explore how advanced multi-transporter models improve understanding of drug transport across the blood-brain barrier in preclinical research.
  • An Arm and a Leg: The accidental architect of America’s drug patent problem
    News - 20 Apr 2026
    Depending on whom you ask, Alfred Engelberg could be a hero or a villain in the story of American pharmaceuticals.
  • Paxlovid
    Drug - 16 Apr 2026
    Consumer Medicine Information (CMI) about Paxlovid intended for persons living in Australia.
  • Clopixol
    Drug - 14 Apr 2026
    Consumer Medicine Information (CMI) about Clopixol intended for persons living in Australia.
  • Maxor Heartburn Relief
    Drug - 2 Apr 2026
    Consumer Medicine Information (CMI) about Maxor Heartburn Relief intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback